These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9542203)

  • 21. HIV-1 dynamics in vivo.
    Ho DD
    J Biol Regul Homeost Agents; 1995; 9(3):76-7. PubMed ID: 8782010
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment.
    Ullum H; Katzenstein T; Aladdin H; Nielsen C; Sondergaard SR; Gerstoft J; Skinhoj P; Pedersen BK
    Scand J Immunol; 1999 May; 49(5):539-47. PubMed ID: 10320648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New drugs--reports of new drugs recently approved by the FDA. Ritonavir.
    Bioorg Med Chem; 1997 Mar; 5(3):461-2. PubMed ID: 9113321
    [No Abstract]   [Full Text] [Related]  

  • 24. Resolution of chronic hepatitis B after ritonavir treatment in an HIV-infected patient.
    Velasco M; Morán A; Téllez MJ
    N Engl J Med; 1999 Jun; 340(22):1765-6. PubMed ID: 10357637
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of discordant immunologic and virologic responses in patients with AIDS under antiretroviral therapy in a specialized care center in Brazil.
    Casotti JA; Passos LN; Oliveira FJ; Cerutti C
    Rev Inst Med Trop Sao Paulo; 2011; 53(6):301-7. PubMed ID: 22183451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surrogacy in HIV-1 clinical trials.
    Pozniak A
    Lancet; 1998 Feb; 351(9102):536-7. PubMed ID: 9492766
    [No Abstract]   [Full Text] [Related]  

  • 27. Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran.
    Kakadiya PP; Higginson RT; Fulco PP
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133562
    [No Abstract]   [Full Text] [Related]  

  • 28. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor.
    Carr A; Cooper DA
    Lancet; 1997 Apr; 349(9057):995-6. PubMed ID: 9100629
    [No Abstract]   [Full Text] [Related]  

  • 29. Ritonavir for advanced HIV infection.
    Am Fam Physician; 1996 Jul; 54(1):372, 374. PubMed ID: 8677846
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group.
    Cohen C; Revicki DA; Nabulsi A; Sarocco PW; Jiang P
    AIDS; 1998 Aug; 12(12):1495-502. PubMed ID: 9727571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of ritonavir for the treatment of HIV disease in children: abstract and commentary.
    Oleske JM; Bagnoud FX
    JAMA; 1998 Jun; 279(22):1831. PubMed ID: 9628719
    [No Abstract]   [Full Text] [Related]  

  • 32. Unusual occurrence of spontaneous haematomas in three asymptomatic HIV-infected haemophilia patients a few days after the onset of ritonavir treatment.
    Ginsburg C; Salmon-Ceron D; Vassilief D; Rabian C; Rotschild C; Fontenay-Roupie M; Stieltjes N; Sicard D
    AIDS; 1997 Mar; 11(3):388-9. PubMed ID: 9147435
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA.
    Akeb F; Ferrua B; Creminon C; Roptin C; Grassi J; Nevers MC; Guedj R; Garraffo R; Duval D
    J Immunol Methods; 2002 May; 263(1-2):1-9. PubMed ID: 12009199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some state space models of HIV pathogenesis under treatment by anti-viral drugs in HIV-infected individuals.
    Tan WY; Xiang Z
    Math Biosci; 1999 Mar; 156(1-2):69-94. PubMed ID: 10204388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
    Valdez H; Purvis SF; Lederman MM; Fillingame M; Zimmerman PA
    JAMA; 1999 Aug; 282(8):734. PubMed ID: 10463706
    [No Abstract]   [Full Text] [Related]  

  • 36. CROI round-up. New information on the heart, plus a possible alternative to Norvir and more.
    Posit Aware; 2009; 20(3):30-1. PubMed ID: 19492446
    [No Abstract]   [Full Text] [Related]  

  • 37. Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!
    Lemaitre F
    Clin Pharmacokinet; 2022 Aug; 61(8):1071-1073. PubMed ID: 35870084
    [No Abstract]   [Full Text] [Related]  

  • 38. Dramatic cutaneous psoriasis improvement in a patient with the human immunodeficiency virus treated with 2',3'-dideoxy,3'-thyacytidine [correction of 2',3'-dideoxycytidine] and ritonavir.
    Berthelot P; Guglielminotti C; Frésard A; Lucht F; Perrot JL
    Arch Dermatol; 1997 Apr; 133(4):531. PubMed ID: 9126015
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy of ritonavir in HIV positive patients pretreated with nucleoside analogues].
    Gómez-Cano M; Soriano V; Polo R; Valencia E; Adrados M; González-Lahoz J
    An Med Interna; 1998 Feb; 15(2):83-6. PubMed ID: 9542203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.